文献速递结核与非结核分枝杆菌

儿童广泛耐药结核治疗结局:全球系统综述与患者荟萃分析

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis.
PubMed 文献 · Emerg Infect Dis · 2019-01-01

该研究纳入11个国家37例经细菌学确诊的广泛耐药结核(XDR TB)儿童(<15岁),分析1999–2013年间的临床表现、治疗与结局。结果显示81%患儿获得良好治疗结局,死亡率11%,明显低于成人;但治疗方案与疗程差异较大。

要点

  • 儿童XDR TB良好治疗结局比例高(81%),死亡率(11%)明显低于成人。
  • 治疗方案与疗程差异大,需在儿童中评估新方案。
  • HIV感染状态需纳入评估,29例有记录者中7例(24%)HIV阳性。

核心结论

  • 儿童XDR TB患者中良好治疗结局比例高,死亡率明显低于成人。

研究设计与样本

  • 全球系统综述与患者荟萃分析,纳入11个国家37例经细菌学确诊的XDR TB儿童(<15岁),管理时间为1999–2013年。

主要发现

  • 37例患儿中位年龄11岁,32例(87%)为肺结核,29例有HIV状态记录,其中7例(24%)HIV阳性。
  • 强化期中位疗程7.0个月,继续期中位疗程12.2个月,治疗方案与疗程差异较大。

临床怎么用

  • 儿童XDR TB治疗结局可能优于成人,但方案差异大,需个体化评估并推动儿童新方案研究。

局限性

  • 样本量小(37例),治疗方案与疗程异质性大,HIV状态记录不全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manifestations, treatment, and outcomes for 37 children (<15 years of age) with bacteriologically confirmed XDR TB in 11 countries. These patients were managed during 1999-2013. For the 37 children, median age was 11 years, 32 (87%) had pulmonary TB, and 29 had a recorded HIV status; 7 (24%) were infected with HIV. Median treatment duration was 7.0 months for the intensive phase and 12.2 months for the continuation phase. Thirty (81%) children had favorable treatment outcomes. Four (11%) died, 1 (3%) failed treatment, and 2 (5%) did not complete treatment. We found a high proportion of favorable treatment outcomes among children, with mortality rates markedly lower than for adults. Regimens and duration of treatment varied considerably. Evaluation of new regimens in children is required.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Osman M, Harausz EP, Garcia-Prats AJ, et al. Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis. Emerg Infect Dis. 2019. PMID: 30789141. doi:10.3201/eid2503.180852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。